Evaluation of a new antibacterial agent, cephaloridine (loridine).
D000328:Adult; D002509:Cephaloridine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D011247:Pregnancy
D002509:Cephaloridine; D002512:Cephalothin